Get started
Author

Jing Long

Observed institutions: Chinese Academy of Sciences, Wenzhou Medical University, Wuhan Institute of Virology, Beijing Dao Pei Hospital, State Key Laboratory of Virology, Tsinghua University
ORCID: 0000-0002-4199-2769
Observed ORCID: 0000-0002-4199-2769
OpenAlex ID: A5014905583
The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma
2021 · Deming Duan, Keke Wang, et al. · Frontiers in Immunology · 97
PDF
The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1
2012 · Shuai Wang, Jing Long, et al. · Protein & Cell · 27
PDF
Plasma Membrane Profiling Reveals Upregulation of ABCA1 by Infected Macrophages Leading to Restriction of Mycobacterial Growth
2016 · Jing Long, Robindra Basu Roy, et al. · Frontiers in Microbiology · 23
PDF
Combination of 4-1BB and DAP10 promotes proliferation and persistence of NKG2D(bbz) CAR-T cells
2022 · Cheng Wei, Kangfu Xia, et al. · Frontiers in Oncology · 16
A novel multimeric sCD19 ‐streptavidin fusion protein for functional detection and selective expansion of CD19 ‐targeted CAR‐T cells
2022 · Hui Lian, Jinhong Jiang, et al. · Cancer Medicine · 3
[Construction of NKG2D CAR-NK92 cells and its killing effect on multiple myeloma cells].
2023 · Jing Long, Rong Zheng, et al. · PubMed · 1
SOHO State of the Art Updates and Next Questions | CD7 CAR-T Therapy for Treating CD7-Positive Hematological Malignancies: Clinical Advances and Future Directions
2025 · Peihua Lu, Jing Long · Clinical Lymphoma Myeloma & Leukemia
Works count: 7
Citation count: 167
H-index: 4
I10-index: 4
Year
Topic
Type